| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 14 |
| 1 | CYCLOPHOSPHAMIDE | 11 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 11 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 11 |
| 4 | PACLITAXEL | 10 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 10 |
| 6 | PANTOPRAZOLE | 9 |
| 7 | OLAPARIB | 8 |
| 8 | CYTARABINE | 6 |
| 9 | AZACITIDINE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PSYLLIUM HUSK | 1 | 0.0007 |
| 1 | RYDAPT | 1 | 0.0005 |
| 2 | CLOFARABINE | 1 | 0.0004 |
| 3 | OLAPARIB | 8 | 0.0004 |
| 4 | MITOXANTRONE HYDROCHLORIDE | 2 | 0.0003 |
| 5 | AZACITIDINE | 5 | 0.0002 |
| 6 | HYDROXYUREA | 3 | 0.0001 |
| 7 | PYRIDOSTIGMINE BROMIDE | 1 | 0.0001 |
| 8 | ATOVAQUONE | 1 | 0.0001 |
| 9 | CARBOPLATIN | 14 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 15 |
| 1 | Alkylating Drug [EPC] | 14 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 11 |
| 3 | Microtubule Inhibitor [EPC] | 10 |
| 4 | Corticosteroid [EPC] | 8 |
| 5 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 8 |
| 6 | Topoisomerase Inhibitor [EPC] | 4 |
| 7 | Antimetabolite [EPC] | 3 |
| 8 | Kinase Inhibitor [EPC] | 3 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 1 | Antimalarial [EPC] | 1 | 0.0001 |
| 2 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 3 | Microtubule Inhibitor [EPC] | 10 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 14 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 15 | 0.0001 |
| 6 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 11 | 0.0000 |
| 8 | Iron Chelator [EPC] | 1 | 0.0000 |
| 9 | Protease Inhibitor [EPC] | 1 | 0.0000 |